Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Methods × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Colorectal Neoplasms 12 Prostatic Neoplasms 11 Lung Neoplasms 10 Neoplasms 8 Lymphoma 6 Uterine Cervical Neoplasms 5 Pancreatic Neoplasms 5 Hematologic Neoplasms 5 Melanoma 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Papillomavirus Infections 3 Ovarian Neoplasms 3 Obesity 3 Neoplasm Metastasis 3 Malignant Solid Neoplasm 3 Hematopoietic and Lymphatic System Neoplasm 3 Breast Carcinoma In Situ 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Smoking Cessation 2 Skin Carcinoma 2 Pain 2 Overweight 2 Obesity-Related Malignant Neoplasm 2 Multiple Myeloma 2 Motor Activity 2 Lymphoma, Non-Hodgkin 2

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡